Curasore Liquid
NDC Package 12258-223-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Curasore (pramoxine hydrochloride) liquids is adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily; avoid moistening area for 2 to 3 minutes following application. This formulation utilizes a liquid delivery system. Marketed by S.s.s. Company, this product is identified by NDC 12258-223 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
12258-223-05
Package Description
1 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE
Product Code
12258-223
11-Digit Billing Format
12258022305
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Curasore
Non-Proprietary Name
Pramoxine Hydrochloride
Substance Name
Pramoxine Hydrochloride
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
PRAMOXINE HYDROCHLORIDE 1 g/100mL
Usage Information
Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily; avoid moistening area for 2 to 3 minutes following application. Children under 2 years of age: consult a doctor.

Regulatory & Marketing

Labeler Name
S.s.s. Company
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-31-1995
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 12258-223-05 identifies a specific commercial package of 1 bottle in 1 carton / 15 ml in 1 bottle of Curasore, a human over the counter drug labeled by S.s.s. Company. This liquid is formulated for topical use and contains pramoxine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by S.s.s. Company on August 31, 1995. The current certification is valid through December 31, 2027.

How is this S.s.s. Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 12258022305. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
12258-223-05
11-Digit CMS (5-4-2)
12258-0223-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.